Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/78216
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Defective lung macrophage function in lung cancer±chronic obstructive pulmonary disease (COPD/emphysema)-mediated by cancer cell production of PGE2?
Other Titles: Defective lung macrophage function in lung cancer +/- chronic obstructive pulmonary disease (COPD/emphysema)-mediated by cancer cell production of PGE2?
Author: Dehle, F.
Mukaro, V.
Jurisevic, C.
Moffat, D.
Ahern, J.
Hodge, G.
Jersmann, H.
Reynolds, P.
Hodge, S.
Citation: PLoS One, 2013; 8(4):1-6
Publisher: Public Library of Science
Issue Date: 2013
ISSN: 1932-6203
1932-6203
Statement of
Responsibility: 
Francis C. Dehle, Violet R. Mukaro, Craig Jurisevic, David Moffat, Jessica Ahern, Greg Hodge, Hubertus Jersmann, Paul N. Reynolds, Sandra Hodge
Abstract: In chronic obstructive pulmonary disease (COPD/emphysema) we have shown a reduced ability of lung and alveolar (AM) macrophages to phagocytose apoptotic cells (defective ‘efferocytosis’), associated with evidence of secondary cellular necrosis and a resultant inflammatory response in the airway. It is unknown whether this defect is present in cancer (no COPD) and if so, whether this results from soluble mediators produced by cancer cells. We investigated efferocytosis in AM (26 controls, 15 healthy smokers, 37 COPD, 20 COPD+ non small cell lung cancer (NSCLC) and 8 patients with NSCLC without COPD) and tumor and tumor-free lung tissue macrophages (21 NSCLC with/13 without COPD). To investigate the effects of soluble mediators produced by lung cancer cells we then treated AM or U937 macrophages with cancer cell line supernatant and assessed their efferocytosis ability. We qualitatively identified Arachidonic Acid (AA) metabolites in cancer cells by LC-ESI-MSMS, and assessed the effects of COX inhibition (using indomethacin) on efferocytosis. Decreased efferocytosis was noted in all cancer/COPD groups in all compartments. Conditioned media from cancer cell cultures decreased the efferocytosis ability of both AM and U937 macrophages with the most pronounced effects occurring with supernatant from SCLC (an aggressive lung cancer type). AA metabolites identified in cancer cells included PGE2. The inhibitory effect of PGE2 on efferocytosis, and the involvement of the COX-2 pathway were shown. Efferocytosis is decreased in COPD/emphysema and lung cancer; the latter at least partially a result of inhibition by soluble mediators produced by cancer cells that include PGE2.
Keywords: Lung; Cell Line, Tumor; Subcellular Fractions; Macrophages, Alveolar; Bronchoalveolar Lavage Fluid; Humans; Lung Neoplasms; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Dinoprostone; Demography; Phagocytosis; Adult; Aged; Middle Aged; Female; Male; Cyclooxygenase 2
Rights: © 2013 Dehle et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
RMID: 0020128020
DOI: 10.1371/journal.pone.0061573
Appears in Collections:Medicine publications

Files in This Item:
File Description SizeFormat 
hdl_78216.pdfPublished version305.08 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.